Oruka Therapeutics, Inc. (ORKA) — Long-term Investment Intensity
Oruka Therapeutics, Inc. (ORKA) has a Long-term Investment Intensity of 29.8% as of September 2025. Long-term investments of $151.76 Million represent 29.8% of total assets of $509.25 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore ORKA operating cash flow to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oruka Therapeutics, Inc. Long-term Investment Intensity (2024–2024)
This chart shows how Oruka Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the intensity stands at 29.8%, reflecting long-term investments of $151.76 Million against total assets of $509.25 Million USD. Explore Oruka Therapeutics, Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Oruka Therapeutics, Inc. (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Oruka Therapeutics, Inc. from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ORKA stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 4.6% | $18.07 Million | $396.02 Million | — |